[Tumor vaccines-therapeutic vaccination against cancer].
Tumorvakzinierung – therapeutische Vakzinierung gegen Krebs.
Adjuvants, immunologic
Antigens, neoplasm
Vaccines, DNA
Vaccines, RNA
Vaccines, peptide
Journal
Der Internist
ISSN: 1432-1289
Titre abrégé: Internist (Berl)
Pays: Germany
ID NLM: 0264620
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
pubmed:
29
5
2020
medline:
21
7
2020
entrez:
29
5
2020
Statut:
ppublish
Résumé
Tumor cells always exhibit differences to normal cells. These differences can be recognized by the immune system, enabling the destruction of tumor cells by T cells, as was impressively demonstrated by the success of immune checkpoint inhibition, e.g., in malignant melanoma. Many cancers, however, do not respond to this kind of therapy. In these cases, vaccination against tumor antigens could be very helpful. Nevertheless, all of the efforts made in this respect during the past 30 years have been virtually futile. With current knowledge and technology there is new hope.
Identifiants
pubmed: 32462251
doi: 10.1007/s00108-020-00814-z
pii: 10.1007/s00108-020-00814-z
doi:
Substances chimiques
Antigens, Neoplasm
0
Cancer Vaccines
0
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM